Lynn Sadowski Mason
Chief Tech/Sci/R&D Officer at Eterna Therapeutics LLC
Network origin in Lynn Sadowski Mason first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 44 | |
| Public Company | Pharmaceuticals: Major | 10 | |
Eterna Therapeutics LLC
 Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Eterna Therapeutics, Inc., Eterna Therapeutics LLC is a clinical-stage biopharmaceutical company based in New York, NY. The company is focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer. Eterna Therapeutics is committed to developing irx-2, a novel cytokine-based therapy, to treat patients with cancer. The active constituents of irx-2, namely interleukin-2 (il-2) and other key cytokines, are postulated to signal, enhance and restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells. Eterna Therapeutics is a late clinical-stage biopharmaceutical company focused on il-2 cytokine-based therapies in treating patients with cancer. Eterna Therapeutics was acquired by NTN Buzztime, Inc. on March 25, 2021 for $213.30 million.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lynn Sadowski Mason via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Corporate Officer/Principal | |
Brooklyn Immunotherapeutics Investors LP
 Brooklyn Immunotherapeutics Investors LP Financial ConglomeratesFinance Brooklyn Immunotherapeutics Investors LP provides investment services. The company is headquartered in Houston, TX. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
| The Johns Hopkins University | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal General Counsel | |
| Georgetown University | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Graduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
TEI Biosciences, Inc.
 TEI Biosciences, Inc. BiotechnologyHealth Technology TEI Biosciences, Inc. develops and distributes novel biologic products for soft tissue repair, reinforcement and reconstruction applications. Its products include SurgiMend 1.0-4.0, SurgiMend-e, SurgiMend PRS, PriMatrix, PriMatrix AG, Durepair, TissueMend and Xenform. The firm’s products are used in general surgery, plastic and reconstructive surgery, trauma, wound care and burns, neurosurgery, orthopedics and urogynecology. The company was founded in 1993 and is headquartered in Waltham, MA. | Biotechnology | President Chief Executive Officer | |
| CELGENE | Biotechnology | President General Counsel | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
| RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GENOCEA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| PORTAGE BIOTECH INC. | Biotechnology | Director/Board Member Chief Operating Officer | |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| The Fuqua School of Business | College/University | Masters Business Admin Masters Business Admin | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | President Director/Board Member | |
| OMEGA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| University of Connecticut | College/University | Undergraduate Degree Graduate Degree | |
| ARVINAS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| University of Glasgow | College/University | Doctorate Degree Doctorate Degree | |
| MORPHOSYS AG | Biotechnology | President | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal | |
| Bristol-Myers Squibb Pharma Co. | Corporate Officer/Principal | ||
| Boys & Girls Clubs of New Jersey | Director/Board Member | ||
| IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal | |
| SYNEOS HEALTH, INC. | Biotechnology | Director/Board Member | |
| Lehigh University | College/University | Undergraduate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Director/Board Member | |
| Gwynedd-Mercy Academy | Director/Board Member | ||
Vita Therapeutics, Inc.
 Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019. | Biotechnology | Director/Board Member | |
| SUNY Upstate Medical University | College/University | Graduate Degree | |
| Chapman University | College/University | Masters Business Admin | |
| REVANCE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 43 |
| Switzerland | 3 |
| France | 2 |
| United Kingdom | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 15 |
| Commercial Services | 3 |
| Technology Services | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 211 |
| Corporate Officer/Principal | 128 |
| Independent Dir/Board Member | 61 |
| Undergraduate Degree | 48 |
| Chief Executive Officer | 46 |
Most connected contacts
| Insiders | |
|---|---|
| Luba Greenwood | 32 |
| Nicholas Singer | 25 |
| Charles Cherington | 23 |
| James Cornelius | 23 |
| Mark Leuchtenberger | 21 |
| Matt Roden | 18 |
| Peter Arduini | 16 |
| Theodore Samuels | 16 |
| Robert Bertolini | 15 |
| Julie Hambleton | 15 |
| Yiannis A. Monovoukas | 15 |
| Allen Wolff | 14 |
| Vladimir Coric | 14 |
| Suketu Upadhyay | 14 |
| Andres Gutiérrez | 13 |
- Stock Market
- Insiders
- Lynn Sadowski Mason
- Company connections
